Le Lézard
Classified in: Health
Subject: AWD

Firelands Scientific, Leading Medical Cannabis Company, Becomes a Certified B Corporation


HURON, Ohio, Oct. 29, 2020 /PRNewswire/ -- Firelands Scientific a leading medical cannabis company announced that it has earned certification as a B Corporation. As a cutting-edge medical cannabis company that is devoted to providing patients with the highest quality, natural sun grown medicine, Firelands Scientific is proud to be the only medical cannabis company to hold this certification. Firelands Scientific joins 3,500 certified B Corporations in 150 industries and 74 countries including brands such as Ben & Jerry's, Patagonia and Seventh Generation who are committed to doing business as a force for good.

Firelands Scientific was founded on the notion that social and environmental impact must be part of the conversation when making business decisions. The company built a state-of-the-art cultivation and manufacturing facility designed from the ground up to reduce the environmental impact of commercial indoor agriculture. The company pursued B Corp certification to provide a robust framework for measuring, managing and reporting its impact on society.

B Corp recognizes businesses across industries making the greatest social and environmental impact. To earn B Corp Certification, Firelands Scientific completed the B Impact Assessment process, which evaluated the company's impact on patients, customers, workers, communities, and the environment. B Corp certification considers every aspect of a business with respect to actual impact, not aspirational goals.

Since 2006, more than 60,000 companies across the globe have participated in the B Impact Assessment, but only 3,500, or less than 6% have been certified. B Corp Certification differs from other common certifications (e.g., organic, free trade, etc.) as it applies to the entire business, not just the production process or the sourcing of a product.

Jeff McCourt, CEO of Firelands Scientific, said, "our values of respect, taking ownership, innovation, and being a force for good in the World are as much a part of our identity as pioneering the industry. Our business is built around purpose. We understand and take very seriously our responsibility to uphold the strict standards of verified social and environmental performance, public transparency, and legal accountability."

"Firelands being granted B Corp status further cements why we chose to work with this Cannabis company and further demonstrates Firelands already strong commitment to sustainability. As we here at Chagrin Valley Soap & Salve have been a model for what organic and sustainable can be in the body care industry, Firelands has become a new leader for sustainability in the Medical Cannabis industry," said Sam Friedman, Director, Chagrin Valley Soap & Salve.

Firelands Scientific's commitment to responsible business practices is evidenced by:

A commitment to all people

A commitment to the environment

A commitment to the Community

Please visit Firelands Scientific to learn more or email [email protected].

SOURCE Firelands Scientific


These press releases may also interest you

at 02:22
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter 2024 First Quarter 2024 Total revenue increased 19 per cent, 20 per cent at constant exchange rates, (CER)1, to SEK 6,256 M (5,239)Haematology revenue...

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...



News published on and distributed by: